Literature DB >> 9199758

Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres.

M Chiba1, J Hanes, R Langer.   

Abstract

Polymer microspheres capable of the controlled release of macromolecules for periods ranging from days to over a month were developed. The microspheres were made using a new family of anhydride polymers: tyrosine-containing poly(anhydride-co-imides), specifically poly[trimellitylimido-L-tyrosine-co-sebacic acid-co-1,3-bis(carboxphenoxy)propane] anhydrides [poly(TMA-Tyr:SA:CPP)]. These polymers may be of particular interest for controlled delivery of vaccine antigens due to the incorporation of an immunological adjuvant, L-tyrosine, into their backbone. Microspheres were produced from a variety of polymer compositions using a double-emulsion solvent-evaporation technique, and tested for their ability to provide controlled release of a model protein, bovine serum albumin, in vitro. The microspheres are spherical with smooth surfaces and encapsulate greater than 70% of the protein. Protein release rates from polymers of identical composition could be varied from 0.3 to over 125 micrograms per mg spheres per month by changing the amount of protein encapsulated. This effect can be magnified by using polymers with various monomer ratios. A close correlation between protein release and polymer weight loss was observed, suggesting a release mechanism controlled mainly by polymer erosion. Bovine serum albumin release from poly(TMA-Tyr:SA:CPP) microspheres is also pH sensitive, being enhanced at high pH and depressed under acidic conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199758     DOI: 10.1016/s0142-9612(97)00027-6

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Enhanced protein delivery from photopolymerized hydrogels using a pseudospecific metal chelating ligand.

Authors:  Chien-Chi Lin; Andrew T Metters
Journal:  Pharm Res       Date:  2006-01-12       Impact factor: 4.200

2.  Multivalent conjugates of basic fibroblast growth factor enhance in vitro proliferation and migration of endothelial cells.

Authors:  Aline Zbinden; Shane Browne; Eda I Altiok; Felicia L Svedlund; Wesley M Jackson; Kevin E Healy
Journal:  Biomater Sci       Date:  2018-05-01       Impact factor: 6.843

3.  Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

Authors:  Scott L Kominsky; Mustafa Vali; Dorian Korz; Theodore G Gabig; Sigmund A Weitzman; Pedram Argani; Saraswati Sukumar
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

4.  Effect of additives on the release of a model protein from PLGA microspheres.

Authors:  F Kang; J Singh
Journal:  AAPS PharmSciTech       Date:  2001-12-17       Impact factor: 3.246

Review 5.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

6.  Preparation and characterization of protein-loaded polyanhydride microspheres.

Authors:  Lin Sun; Shaobing Zhou; Weijia Wang; Qiuxiang Su; Xiaohong Li; Jie Weng
Journal:  J Mater Sci Mater Med       Date:  2009-05-08       Impact factor: 3.896

7.  Engineering of poly(epsilon-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic.

Authors:  Valentina Coccoli; Alessia Luciani; Silvia Orsi; Vincenzo Guarino; Filippo Causa; Paolo Antonio Netti
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

8.  Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline.

Authors:  Alireza Mahboubian; Seyyed Kazem Hashemein; Shadi Moghadam; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.